MedPath

Effectiveness of a 12-week self-myofascial release therapy on pain and tendon stiffness in active recreational runners with self-reported Achilles tendon complaints

Completed
Conditions
Achilles tendon complaints (pain
stiffness)
10043237
Registration Number
NL-OMON44629
Lead Sponsor
Vrije Universiteit Medisch Centrum
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Completed
Sex
Not specified
Target Recruitment
74
Inclusion Criteria

active recreational runners older than 18 years, self-reported achilles tendon complaints (pain, stiffness)

Exclusion Criteria

(1) presence of severe cardiovascular, neurologic, endocrine, psychiatric, or orthopaedic diseases (except Achilles tendinopathy); (2) simultaneous participation in other studies; (3) pregnancy or nursing period; (4) regular intake of analgesic drugs (5) symptoms to severe that they cause complete *inability to run*, (6) younger than 18 years of age.

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
<p>The following primary outcomes will be assessed at baseline and post-treatment<br /><br>(12 weeks after baseline).<br /><br><br /><br>- VISA-A score<br /><br>- Mechanical pain threshold<br /><br>- Self-perceived clinical progress (GROC)<br /><br><br /><br>VISA-A and GROC will also be assessed every week throughout the study.</p><br>
Secondary Outcome Measures
NameTimeMethod
<p>A web-based log will be developed in order to collect data on:<br /><br><br /><br>- running exposure (hours/week, km/week, and times/week);<br /><br>- level of pain during running assessed with an 11-point NRS (0 to 10);<br /><br>- adherence to the assigned treatment (SMR or ECC); and<br /><br>- competing interventions (performance of other interventions alongside with<br /><br>the assigned treatment including medication).<br /><br><br /><br>Data on these secondary outcomes will be collected every week throughout the<br /><br>study (12 weeks).</p><br>
© Copyright 2025. All Rights Reserved by MedPath